EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 3.39 Delayed Data As of Dec 02 |  +0.19 / +5.94%Today’s Change | 2.97 Today|||52-Week Range 15.74 | -72.30% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Duker Jay S Chief Operating Officer |  Sale | 11/01/2022 | 4,479 | $5.42 | $24.3K | -37.45% |
Paggiarino Dario A Chief Medical Officer | Sale | 2/09/2022 | 1,721 | $10.13 | $17.4K | -66.54% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Sale | 2/09/2022 | 1,473 | $10.13 | $14.9K | -66.54% |
Paggiarino Dario A Chief Medical Officer | Sale | 2/28/2022 | 1,294 | $9.95 | $12.9K | -65.93% |
Pine Michael C |  Buy | 3/14/2022 | 1,000 | $12.21 | $12.2K | -72.33% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Sale | 2/28/2022 | 1,130 | $9.95 | $11.2K | -65.93% |
Lurker Nancy Sue President & Chief Executive Officer | Buy | 2/09/2022 | 17,533 | $0.00 | $0.00 | -66.54% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Buy | 2/09/2022 | 4,966 | $0.00 | $0.00 | -66.54% |
Paggiarino Dario A Chief Medical Officer | Buy | 2/09/2022 | 4,966 | $0.00 | $0.00 | -66.54% |
Guyer David R Director | Buy | 2/09/2022 | 2,500 | $0.00 | $0.00 | -66.54% |
Page of 2